133 related articles for article (PubMed ID: 36591157)
1. Stability of Phenyl-Modified Triphenylphosphonium Conjugates and Interactions with DTPA.
Gruenwald HK; Kerns RJ
ACS Omega; 2022 Dec; 7(51):48332-48339. PubMed ID: 36591157
[TBL] [Abstract][Full Text] [Related]
2. A Novel Triphenylphosphonium Carrier to Target Mitochondria without Uncoupling Oxidative Phosphorylation.
Kulkarni CA; Fink BD; Gibbs BE; Chheda PR; Wu M; Sivitz WI; Kerns RJ
J Med Chem; 2021 Jan; 64(1):662-676. PubMed ID: 33395531
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.
Battogtokh G; Choi YS; Kang DS; Park SJ; Shim MS; Huh KM; Cho YY; Lee JY; Lee HS; Kang HC
Acta Pharm Sin B; 2018 Oct; 8(6):862-880. PubMed ID: 30505656
[TBL] [Abstract][Full Text] [Related]
4. Triphenylphosphonium-conjugated glycol chitosan microspheres for mitochondria-targeted drug delivery.
Lee YH; Park HI; Chang WS; Choi JS
Int J Biol Macromol; 2021 Jan; 167():35-45. PubMed ID: 33227331
[TBL] [Abstract][Full Text] [Related]
5. Effect of the Conjugation Density of Triphenylphosphonium Cation on the Mitochondrial Targeting of Poly(amidoamine) Dendrimers.
Bielski ER; Zhong Q; Brown M; da Rocha SR
Mol Pharm; 2015 Aug; 12(8):3043-53. PubMed ID: 26158804
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobized triphenyl phosphonium derivatives for the preparation of mitochondriotropic liposomes: choice of hydrophobic anchor influences cytotoxicity but not mitochondriotropic effect.
Benien P; Solomon MA; Nguyen P; Sheehan EM; Mehanna AS; D'Souza GG
J Liposome Res; 2016; 26(1):21-7. PubMed ID: 25811811
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Anticancer, and Antibacterial Activity of Betulinic and Betulonic Acid C-28-Triphenylphosphonium Conjugates with Variable Alkyl Linker Length.
Tsepaeva OV; Nemtarev AV; Salikhova TI; Abdullin TI; Grigor Eva LR; Khozyainova SA; Mironov VF
Anticancer Agents Med Chem; 2020; 20(3):286-300. PubMed ID: 31660842
[TBL] [Abstract][Full Text] [Related]
8. A new triphenylphosphonium-conjugated amphipathic cationic peptide with improved cell-penetrating and ROS-targeting properties.
Ishkaeva RA; Salakhieva DV; Garifullin R; Alshadidi R; Laikov AV; Yergeshov AA; Kamalov MI; Abdullin TI
Curr Res Pharmacol Drug Discov; 2023; 4():100148. PubMed ID: 36593927
[TBL] [Abstract][Full Text] [Related]
9. Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis.
Li WQ; Wu JY; Xiang DX; Luo SL; Hu XB; Tang TT; Sun TL; Liu XY
Int J Nanomedicine; 2019; 14():8345-8360. PubMed ID: 31695371
[TBL] [Abstract][Full Text] [Related]
10. Triphenylphosphonium Moiety Modulates Proteolytic Stability and Potentiates Neuroprotective Activity of Antioxidant Tetrapeptides
Akhmadishina RA; Garifullin R; Petrova NV; Kamalov MI; Abdullin TI
Front Pharmacol; 2018; 9():115. PubMed ID: 29520232
[TBL] [Abstract][Full Text] [Related]
11. Enabling Mitochondrial Uptake of Lipophilic Dications Using Methylated Triphenylphosphonium Moieties.
Ong HC; Hu Z; Coimbra JTS; Ramos MJ; Kon OL; Xing B; Yeow EKL; Fernandes PA; García F
Inorg Chem; 2019 Jul; 58(13):8293-8299. PubMed ID: 31184865
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of delocalized lipophilic cationic dyes as delivery vehicles for photosensitizers to mitochondria.
Ngen EJ; Rajaputra P; You Y
Bioorg Med Chem; 2009 Sep; 17(18):6631-40. PubMed ID: 19692249
[TBL] [Abstract][Full Text] [Related]
13. The mitochondria-targeted imidazole substituted oleic acid 'TPP-IOA' affects mitochondrial bioenergetics and its protective efficacy in cells is influenced by cellular dependence on aerobic metabolism.
Maddalena LA; Ghelfi M; Atkinson J; Stuart JA
Biochim Biophys Acta Bioenerg; 2017 Jan; 1858(1):73-85. PubMed ID: 27836699
[TBL] [Abstract][Full Text] [Related]
14. Selective Delivery of Dicarboxylates to Mitochondria by Conjugation to a Lipophilic Cation via a Cleavable Linker.
Prag HA; Kula-Alwar D; Pala L; Caldwell ST; Beach TE; James AM; Saeb-Parsy K; Krieg T; Hartley RC; Murphy MP
Mol Pharm; 2020 Sep; 17(9):3526-3540. PubMed ID: 32692564
[TBL] [Abstract][Full Text] [Related]
15. The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium-Resveratrol Conjugate on Breast Cancer Cells.
Jiang L; Yu H; Wang C; He F; Shi Z; Tu H; Ning N; Duan S; Zhao Y
Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297383
[TBL] [Abstract][Full Text] [Related]
16. Induction of autophagy by depolarization of mitochondria.
Lyamzaev KG; Tokarchuk AV; Panteleeva AA; Mulkidjanian AY; Skulachev VP; Chernyak BV
Autophagy; 2018; 14(5):921-924. PubMed ID: 29458285
[TBL] [Abstract][Full Text] [Related]
17. Novel triphenylphosphonium amphiphilic conjugates of glycerolipid type: synthesis, cytotoxic and antibacterial activity, and targeted cancer cell delivery.
Tsepaeva OV; Nemtarev AV; Pashirova TN; Khokhlachev MV; Lyubina AP; Amerkhanova SK; Voloshina AD; Mironov VF
RSC Med Chem; 2023 Mar; 14(3):454-469. PubMed ID: 36970146
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria.
Rajaputra P; Nkepang G; Watley R; You Y
Bioorg Med Chem; 2013 Jan; 21(2):379-87. PubMed ID: 23245573
[TBL] [Abstract][Full Text] [Related]
19. Incorporating a Polyethyleneglycol Linker to Enhance the Hydrophilicity of Mitochondria-Targeted Triphenylphosphonium Constructs.
Uno S; Harkiss AH; Chowdhury R; Caldwell ST; Prime TA; James AM; Gallagher B; Prudent J; Hartley RC; Murphy MP
Chembiochem; 2023 Jun; 24(11):e202200774. PubMed ID: 36917207
[TBL] [Abstract][Full Text] [Related]
20. Bioreducible Poly(ethylene glycol)-Triphenylphosphonium Conjugate as a Bioactivable Mitochondria-Targeting Nanocarrier.
Khatun Z; Choi YS; Kim YG; Yoon K; Nurunnabi M; Li L; Lee E; Kang HC; Huh KM
Biomacromolecules; 2017 Apr; 18(4):1074-1085. PubMed ID: 28257184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
